Social Media Newsroom


Artemis DNA is a full service, Clinical Laboratory Improvement Amendments (CLIA) certified, College of American Pathologists (CAP) accredited, high-complexity clinical diagnostic laboratory company that provides proprietary Next Generation Sequencing (NGS) genetic testing and diagnostic laboratory services for a wide variety of medical specialties, including cardiology, oncology, immunology, neurology, reproductive health and pharmacogenomics. Artemis DNA’s testing enhances the delivery of “personalized medicine” by assessing a patient’s own genetic makeup and clinical characteristics which allows for informed decision making in prevention and treatment choices.  Artemis DNA also provides pre- and post-testing genetic education and counseling services, as well as conducting research and development to discover and develop additional novel diagnostic services. Artemis DNA is headquartered in Irvine, California. For more information, visit


Press Contact

Emylee Thai
(888) 883-6288, Extension 8
Contact Us

Press Releases

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California

More Released on June 15, 2022

Artemis DNA Forays Into Multi-Billion Dollar Cancer Liquid Biopsy Market

More Released on June 6, 2022

Artemis DNA Announces Global Expansion, Begins Offering Genetic Testing and Early Detection of Cancer Technology to Vietnam

More Released on April 11, 2022

Artemis DNA Clinical Medical Laboratory Receives Second Accreditation From the College of American Pathologists

More Released on February 2, 2022

Artemis DNA, Genetic Testing Company, Reserves 100 VinFast EV as part of ESG Initiatives

More Released on January 9, 2022